MedPath

Propofol/Dexmedetomidine Versus Desflurane Effects on Post Hepatectomy Hepatocellular Injury

Early Phase 1
Recruiting
Conditions
Hepatectomy
Interventions
Registration Number
NCT05246371
Lead Sponsor
Ain Shams University
Brief Summary

This study will compare the effects of propofol/dexmedetomidine versus desflurane for maintenance of general anesthesia on hepatocellular injury in patients undergoing partial hepatectomy.

Detailed Description

Postoperative impairment of liver function is common after hepatectomy. It may be caused by surgical trauma, loss of hepatic mass, stress response, hepatic oxygen deprivation, infection and drug toxicity.

Anesthetic agents used in general anesthesia for liver surgery have a big effect on hepatic blood flow, oxygen delivery and liver function This study will compare the effects of propofol/dexmedetomidine versus desflurane for maintenance of general anesthesia on hepatocellular injury in patients undergoing partial hepatectomy.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Patients American Society of Anesthesiologists physical status (ASA) I to II.
  2. Patients Child Pugh classification A to B.
  3. Both sexes.
  4. Aged between 18 years and 70 years
  5. Scheduled for more than 1 segment hepatectomy.
Exclusion Criteria
  1. Patients with Child Pugh classification C.
  2. Patients younger than18 years old or older than 70 years old
  3. Patients performed additional ablation therapies (cryosurgery or radiofrequency ablation).
  4. Prior liver resection for donation.
  5. Scheduled resection not requiring inflow occlusion (Pringle's maneuver).
  6. Hypersensitivity to any of the used drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
desfluraneDesfluranePatients will receive maintenance of general anesthesia by desflurane.
propofol and dexmedetomidinePropofol, dexmedetomidinePatients will receive maintenance of general anesthesia by TIVA using combination of propofol and dexmedetomidine
Primary Outcome Measures
NameTimeMethod
bilirubin1 week

bilirubin

albumin1 week

albumin

aspartate aminotransferase (AST)1 week

aspartate aminotransferase (AST)

alanine aminotransferase (ALT)1 week

alanine aminotransferase (ALT)

prothrombin time1 week

prothrombin time

INR1 week

INR

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ain Shams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath